CYP19A1 and breast carcinoma: Usage of multiple exons 1 of the aromatase gene and mRNA levels of aromatase were examined by reverse transcription-polymerase chain reaction analysis in breast tissues of 38 elderly patients with breast cancer (age 80–99), and the results were compared with those in 35 patients of the control group (age 37–70).